TRPM8,CD47和CDK4表达在肝细胞癌进展中的影响
Aiat Shaban Hemida1, Mona Saeed Tantawy2
1Pathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
Journal of immunoassay & immunochemistry
|February 17, 2025
概括
这项研究揭示了TRPM8,CD47和CDK4在肝细胞癌 (HCC) 中高度表达,与预后不佳相关,并可能成为HCC发展和进展的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- TRPM8在肝细胞癌 (HCC) 发展中的作用尚不清楚.
- CD47涉及瘤免疫逃逸和巨细胞消化.
- CDK4是已知的癌症发生的驱动因素.
研究的目的:
- 为了研究TRPM8,CD47和CDK4在HCC中的表达水平.
- 确定这些标记物之间的相关性及其在HCC中的预后意义.
- 探索TRPM8,CD47和CDK4在HCC中的潜在协同作用.
主要方法:
- 在101个HCC组织和82个邻近的非瘤肝组织中对TRPM8,CD47和CDK4表达的免疫组织化学分析.
- 统计分析以评估表达差异,与预后因素的相关性和生存结果.
主要成果:
- 与非瘤性肝脏组织相比,在HCC中观察到TRPM8,CD47和CDK4的显著更高的表达 (p < 0.001).
- 这些标记物的高表达与不良预后指标有关,包括高瘤等级,晚期,微血管入侵和.
- 低CDK4表达与延长的整体存活率相关 (p = 0.019).
结论:
- TRPM8,CD47和CDK4在HCC瘤发生过程中表现出协同作用,并与不良的预后意义有关.
- TRPM8和CDK4可能在肝硬化引起的HCC的发展中发挥作用.
- 这些分子代表了HCC干预的潜在治疗点.
关键词:
CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4肝细胞癌是肝细胞癌.在TRPM8中,我们可以使用TRPM8.更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
35.9K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
